News
Global Cannabis News & Analysis | Business of Cannabis
News · page 11
- CBD Market
Greece Moves to Ban Hemp Flower Sales, Despite Government Advisory Body Warning of ‘Conflict’ With EU Law
Last week (April 27), the deadline for Greek industry stakeholders to have their say on a controversial new hemp ban expired.
- US & Canada
‘Not Immediately Compliant’: What the CRS Says America’s Rescheduling Order Actually Delivers
Since President Trump issued an executive order to expedite cannabis rescheduling in December 2025, questions over the legal implications of this route have hung over the industry.
- Cannabis Daily News
Cannabis News Today — Thursday 7 May 2026: Rescheduling Pressure Builds as White House Sounds Potency Alarm
Today’s cannabis news is dominated by rescheduling momentum, with operators racing to secure DEA Schedule III status even as the White House raises fresh concerns over high-potency products, while the UK, Brazil and Idaho underline how rapidly access is broadening on multiple fronts.
- CBD Market
America’s CBD Industry Now Faces Same Evidential Battle Europe Has Been Fighting for 8 Years
The long and arduous journey to regulate cannabidiol (CBD) in Europe, which began in 2018 with the European Union’s classification of CBD as a ‘novel food’, is now playing out in the courtrooms of the United States.
- Cannabis Daily News
Cannabis News Today — Wednesday 6 May 2026: Federal Pressure Mounts as UK Hits Medical Manufacturing Milestone
Trump targets hemp products, DEA pushes medical cannabis operators toward Schedule III registration, a major lawsuit hits industry therapeutic claims, Curaleaf marks a UK manufacturing first, and Virginia’s adult-use sales bill awaits the governor’s signature.
- Medical Cannabis
Curaleaf Laboratories Becomes First UK Manufacturer of Medical Cannabis Suppositories and Pessaries
Curaleaf Laboratories Becomes First UK Manufacturer of Medical Cannabis Suppositories and Pessaries Curaleaf Laboratories today announced a significant milestone in the advancement of medical cannabis treatments in the United Kingdom, becoming the first licensed manufacturer in the country to develop and produce medical cannabis suppositories and pessaries.
- Cannabis Daily News
Cannabis News Today — Tuesday 5 May 2026: DEA Floodgates Open as Industry Races to Register
Cannabis drugmakers prepare for IPOs, nearly 400 operators rush to register with the DEA, microdosing data reframes consumer use patterns, and regulators from Israel to the Bahamas reshape their frameworks as Schedule III aftershocks ripple worldwide.
- CBD Market
The War on Europe’s Legal Hemp Industry
In April 2025, the Italian government used emergency constitutional powers to bypass parliament and reclassify non-intoxicating hemp as a narcotic, regardless of THC content, following multiple failed attempts to decimate the industry.
- M&A Activity
Curaleaf Completes Full Acquisition of Germany’s Four 20 Pharma
Curaleaf Holdings has completed the buyout of the remaining 45% stake in Four 20 Pharma GmbH, making the Paderborn-based medical cannabis producer and distributor a wholly owned subsidiary of the international cannabis giant.
- Cannabis Daily News
Cannabis News Today — Friday 1 May 2026: Schedule III Aftershocks Reshape Industry Outlook
Reclassification confusion, an IPO revival in cannabis pharma and a contentious DEA registration form dominate today’s cannabis news, alongside fresh European consolidation and a return of investor focus on the sector’s ETFs.
- Pharmaceutical
German Distributor Fette Pharma Emerges From Restructuring Under New Investor Leadership
German medicinal cannabis distributor Fette Pharma GmbH has reported the successful completion of a strategic restructuring, almost seven months after an investor consortium led by entrepreneur Jörg Löser acquired the Egelsbach-based company in September 2025.
- Cannabis Daily News
Cannabis News Today — Thursday 30 April 2026: Branson Backs UK Reform as Indiana Reconsiders Legalisation
Reform momentum builds on both sides of the Atlantic as Richard Branson presses for UK cannabis change, Indiana’s governor signals openness to legalisation, and analysts map the banking access unlocked by US rescheduling.
